Evidence map›Paper›PMID 24858807›Full record

ArticlePloS one2014

Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.

Christine Wandall-Frostholm, Lykke Moran Skaarup, Veeranjaneyulu Sadda, Gorm Nielsen, Elise Røge Hedegaard, Susie Mogensen, Ralf Köhler, Ulf Simonsen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Involvement of CaBioscience reports · 2017
    Article
  8. Down-regulation of KScientific reports · 2017
    Article
  9. Article
  10. Genetic deficit of KBritish journal of pharmacology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Christine Wandall-FrostholmDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Lykke Moran SkaarupDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Veeranjaneyulu SaddaDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Institute for Molecular Medicine, Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
Gorm NielsenInstitute for Molecular Medicine, Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
Elise Røge HedegaardDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Susie MogensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Ralf KöhlerInstitute for Molecular Medicine, Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark; Aragon Institute of Health Sciences I+CS and ARAID, Zaragoza, Spain.
Ulf SimonsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Aarhus University · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn vascular biology, endothelial KCa2.3 and KCa3.1 channels contribute to arterial blood pressure regulation by producing membrane hyperpolarization and smooth muscle relaxation. The role of KCa2.3 and KCa3.1 channels in the pulmonary circulation is not fully established. Using mice with genetically encoded deficit of KCa2.3 and KCa3.1 channels, this study investigated the effect of loss of the channels in hypoxia-induced pulmonary hypertension. APPROACH AND

resultMale wild type and KCa3.1-/-/KCa2.3T/T(+DOX) mice were exposed to chronic hypoxia for four weeks to induce pulmonary hypertension. The degree of pulmonary hypertension was evaluated by right ventricular pressure and assessment of right ventricular hypertrophy. Segments of pulmonary arteries were mounted in a wire myograph for functional studies and morphometric studies were performed on lung sections. Chronic hypoxia induced pulmonary hypertension, right ventricular hypertrophy, increased lung weight, and increased hematocrit levels in either genotype. The KCa3.1-/-/KCa2.3T/T(+DOX) mice developed structural alterations in the heart with increased right ventricular wall thickness as well as in pulmonary vessels with increased lumen size in partially- and fully-muscularized vessels and decreased wall area, not seen in wild type mice. Exposure to chronic hypoxia up-regulated the gene expression of the KCa2.3 channel by twofold in wild type mice and increased by 2.5-fold the relaxation evoked by the KCa2.3 and KCa3.1 channel activator NS309, whereas the acetylcholine-induced relaxation - sensitive to the combination of KCa2.3 and KCa3.1 channel blockers, apamin and charybdotoxin - was reduced by 2.5-fold in chronic hypoxic mice of either genotype.

conclusionDespite the deficits of the KCa2.3 and KCa3.1 channels failed to change hypoxia-induced pulmonary hypertension, the up-regulation of KCa2.3-gene expression and increased NS309-induced relaxation in wild-type mice point to a novel mechanism to counteract pulmonary hypertension and to a potential therapeutic utility of KCa2.3/KCa3.1 activators for the treatment of pulmonary hypertension.

Indexed as

AnimalsDoxycyclineGene Expression RegulationHemodynamicsHypertension, PulmonaryHypertrophy, Right VentricularHypoxiaIntermediate-Conductance Calcium-Activated Potassium ChannelsMaleMiceRNA, MessengerSmall-Conductance Calcium-Activated Potassium ChannelsVasodilationDoxycyclineIntermediate-Conductance Calcium-Activated Potassium ChannelsKcnn3 protein, mouseKcnn4 protein, mouseRNA, MessengerSmall-Conductance Calcium-Activated Potassium Channels

Identifiers

PMID24858807
PMCPMC4032241
OpenAlexW2059453871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.